Magazine
September 28, 2026
Innovation Is Driving a New Bull Market in Biotech. 16 Picks From Our Roundtable Pros.
Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our healthcare panel says.
Trump Calls Xi Meeting ‘Very Productive.’ What Investors Might Not Like.
The two leaders appear intent on preserving stability.
4 minute read
Meta Stock Soared 27% on Muse AI. The Hard Part Comes Next.
The meteoric rise of Meta’s fortunes over the past three weeks will be challenging to maintain.
Long Read
Brookfield Has an Enviable Record of Boosting Profits. Its Stock Looks Cheap.
The Canadian alternative-asset manager is valued at 55% of a recent estimate of its asset value.
Long Read
The AI ‘Jobpocalypse’ Isn’t Happening. Here’s What the Data Actually Shows.
New research suggests the technology is creating new roles rather than wiping out all white-collar work.
Long Read
This Company’s Software Manages Supply Chains for Retailers. Its Stock Can Surge 30%.
SPS Commerce has recovered almost all SaaSpocalypse losses and is poised to rally further from here.
Long Read
Paper Bottles Are Coming to Store Shelves. Brands From PepsiCo to Diageo Are Buying In.
Tightening regulations for plastic and a renewed recycling push have consumer brands rethinking their packaging.
Long Read
Can You Chart Your Way to Riches? The Hoopla and Heartbreak of Technical Analysis.
Asset prices already reflect all available information, and technical analysts believe they can discern future stock movements by studying patterns.
Long Read
Dell Top Executives Sell $32 Million in Stock as AI Rally Accelerates
Notable insiders at the company, including its chief financial officer, unloaded millions of dollars worth of Dell stock.
2 minute read
Lennar Stock Is Depressed. Why Berkshire Hathaway Is Piling In.
Berkshire bought the shares Thursday, Friday, and Monday according to a filing with the SEC.
4 minute read
